Targeting human langerin promotes HIV-1 specific humoral immune responses.
Kervevan J, Bouteau A, Lanza JS, Hammoudi A, Zurawski S, Surenaud M, Dieudonné L, Bonnet M, Lefebvre C, Hocini H, Marlin R, Guguin A, Hersant B, Hermeziu O, Menu E, Lacabaratz C, Lelièvre JD, Zurawski G, Godot V, Henri S, Igyártó BZ, Levy Y, Cardinaud S.
Kervevan J, et al. Among authors: igyarto bz.
PLoS Pathog. 2021 Jul 29;17(7):e1009749. doi: 10.1371/journal.ppat.1009749. eCollection 2021 Jul.
PLoS Pathog. 2021.
PMID: 34324611
Free PMC article.